Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Sell
13,602
-1,635
-11% -$60.6K ﹤0.01% 280
2025
Q4
$476K Sell
15,237
-359,400
-96% -$11.1M ﹤0.01% 287
2025
Q3
$12.3M Sell
374,637
-132,663
-26% -$4.61M 0.06% 134
2025
Q2
$16.4M Sell
507,300
-947
-0.2% -$32.8K 0.08% 124
2025
Q1
$18.9M Buy
508,247
+45,123
+10% +$1.87M 0.1% 116
2024
Q4
$18.9M Buy
463,124
+30,859
+7% +$1.49M 0.1% 115
2024
Q3
$21.8M Buy
432,265
+24,243
+6% +$1.11M 0.11% 109
2024
Q2
$17.8M Buy
408,022
+3,218
+0.8% +$141K 0.1% 110
2024
Q1
$17.6M Buy
404,804
+26,135
+7% +$1.02M 0.1% 110
2023
Q4
$15.7M Sell
378,669
-121,412
-24% -$4.24M 0.09% 114
2023
Q3
$17.7M Buy
500,081
+33,425
+7% +$1.29M 0.11% 105
2023
Q2
$19.1M Buy
466,656
+30,777
+7% +$1.21M 0.12% 98
2023
Q1
$17.9M Sell
435,879
-17,504
-4% -$698K 0.1% 101
2022
Q4
$15.3M Buy
453,383
+19,139
+4% +$629K 0.1% 101
2022
Q3
$13.2M Buy
434,244
+10,239
+2% +$424K 0.09% 96
2022
Q2
$17M Buy
424,005
+156,688
+59% +$7.4M 0.11% 90
2022
Q1
$12.8M Sell
267,317
-64,892
-20% -$3.35M 0.09% 97
2021
Q4
$18.6M Buy
332,209
+12,423
+4% +$680K 0.1% 88
2021
Q3
$14.8M Buy
319,786
+27,679
+9% +$1.33M 0.09% 96
2021
Q2
$14.4M Buy
292,107
+18,114
+7% +$916K 0.09% 94
2021
Q1
$13M Buy
273,993
+101,239
+59% +$4.51M 0.08% 96
2020
Q4
$6.96M Buy
172,754
+99,297
+135% +$3.5M 0.04% 128
2020
Q3
$1.94M Sell
73,457
-1,141
-2% -$29.8K 0.01% 226
2020
Q2
$1.96M Sell
74,598
-100
-0.1% -$2.32K 0.01% 219
2020
Q1
$1.42M Sell
74,698
-1,278
-2% -$35.8K 0.01% 227
2019
Q4
$2.79M Sell
75,976
-6,410
-8% -$209K 0.02% 204
2019
Q3
$2.69M Sell
82,386
-594
-0.7% -$18.8K 0.02% 200
2019
Q2
$2.6M Sell
82,980
-56,954
-41% -$1.6M 0.02% 200
2019
Q1
$4.1M Sell
139,934
-6,721
-5% -$211K 0.04% 146
2018
Q4
$4.19M Buy
146,655
+12,450
+9% +$417K 0.04% 128
2018
Q3
$5.87M Buy
134,205
+2,428
+2% +$106K 0.08% 107
2018
Q2
$5.7M Buy
131,777
+2,696
+2% +$116K 0.06% 114
2018
Q1
$5.49M Buy
129,081
+17,371
+16% +$750K 0.06% 113
2017
Q4
$4.86M Buy
111,710
+5,995
+6% +$263K 0.05% 123
2017
Q3
$4.23M Buy
105,715
+10,990
+12% +$410K 0.05% 128
2017
Q2
$3.67M Buy
94,725
+5,348
+6% +$199K 0.04% 133
2017
Q1
$3.05M Buy
89,377
+6,385
+8% +$214K 0.04% 145
2016
Q4
$2.66M Buy
82,992
+7,715
+10% +$248K 0.03% 149
2016
Q3
$2.54M Buy
75,277
+13,450
+22% +$466K 0.03% 151
2016
Q2
$2.18M Buy
61,827
+2,115
+4% +$74.6K 0.03% 164
2016
Q1
$1.81M Buy
59,712
+12,221
+26% +$336K 0.02% 170
2015
Q4
$1.51M Buy
47,491
+2,240
+5% +$74.9K 0.02% 186
2015
Q3
$1.33M Buy
45,251
+3,195
+8% +$108K 0.02% 196
2015
Q2
$1.65M Buy
42,056
+1,200
+3% +$46.9K 0.02% 189
2015
Q1
$1.53M Buy
40,856
+12,573
+44% +$477K 0.02% 189
2014
Q4
$1.07M Buy
28,283
+13,868
+96% +$506K 0.02% 212
2014
Q3
$513K Buy
+14,415
New +$566K 0.01% 282

Other funds holding AVNT

Bahl & Gaynor's AVNT Position: Q1 2026 in Review

Bahl & Gaynor reduced its Avient (AVNT) stake by 11% in Q1 2026, selling an estimated $60.6K and leaving 13,602 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Bahl & Gaynor first reported a position in AVNT in Q3 2014 and has held it in 47 quarters since. The position peaked at $21.8M in Q3 2024. 342 funds tracked by Wall St. Rank hold AVNT as of Q1 2026.

  • Bahl & Gaynor held 13,602 shares of Avient worth $494K as of Q1 2026.
  • Bahl & Gaynor sold 1,635 Avient shares in Q1 2026, an estimated $60.6K.
  • Avient made up ﹤0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #280 holding.
  • Bahl & Gaynor first reported a position in Avient in Q3 2014 and has held it in 47 quarters since.
  • Bahl & Gaynor's Avient position peaked at $21.8M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held Avient as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.